Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...
Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...
MedPage Today on MSN12d
Investigational ADC Shows Promise in Advanced Endometrial CancerPuxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...
etc.) the colocatome documents the details of malignant cells on their neighbors—what those cells are and how many of them are present. "We've been studying cancer cells for so long, but the ...
Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China ...
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape, particularly for advanced and metastatic RCC, where ICI-based combinations have shown substantial improvements in ...
Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma Anti–vascular endothelial growth factor therapy enhances PD-1 ...
SGLT2 inhibitors (versus placebo ... medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751 ...
A novel, allosteric and highly potent USP1 inhibitor, LAE120 exhibits robust tumor inhibitory activity across various xenograft models Significantly accelerated the progress of drug discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback